February, 2003
© 2000, 2001 Scott S. Emerson, M.D., Ph.D.
Session 3: 71
Monitoring Secondary Endpoints
Presentation of results to the DSMB (cont.)
If an issue arises where stopping a trial for safety reasons is potentially indicated, it is useful to have some sort of guideline available for reference